| 000 | 01063 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514064628.0 | ||
| 264 | 0 | _c20030506 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 024 | 7 |
_a10.1001/jama.289.16.2071-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLardinois, Claude K | |
| 245 | 0 | 0 |
_aLipid-lowering therapy and risk of coronary events. _h[electronic resource] |
| 260 |
_bJAMA _c |
||
| 300 |
_a2071; author reply 2071-2 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypercholesterolemia _xcomplications |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tJAMA _gvol. 289 _gno. 16 _gp. 2071; author reply 2071-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.289.16.2071-b _zAvailable from publisher's website |
| 999 |
_c12500738 _d12500738 |
||